Zoetis (ZTS) Deferred Taxes (2012 - 2026)
Zoetis' (ZTS) quarterly Deferred Taxes came in at $34.0 million in Q1 2026, up 142.86% year-on-year from $14.0 million in Q1 2025, and up 170.83% on a QoQ basis from -$48.0 million in Q4 2025.
Zoetis (ZTS) Deferred Taxes (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Deferred Taxes data on file, last reported at $34.0 million in Q1 2026.
- On a quarterly basis, Deferred Taxes rose 142.86% year-over-year to $34.0 million in Q1 2026; TTM through Mar 2026 was -$32.0 million, a 88.61% increase from a year earlier, with the FY2025 full-year figure at -$52.0 million, up 84.62% from the prior year.
- Deferred Taxes for Q1 2026 stood at $34.0 million, up from -$48.0 million in the prior quarter.
- Over the last five years, Deferred Taxes for ZTS reached as high as $34.0 million in Q1 2026 and fell as low as -$176.0 million in Q4 2022.
- Historically, Deferred Taxes has averaged -$41.4 million across 5 years, with a median of -$34.0 million in 2022.
- Across the five-year window, Deferred Taxes sank 637.5% in 2024 and jumped 142.86% in 2026, its largest moves.
- Year by year, Deferred Taxes stood at -$176.0 million in 2022, then surged by 88.07% to -$21.0 million in 2023, then plunged by 623.81% to -$152.0 million in 2024, then soared by 68.42% to -$48.0 million in 2025, then soared by 170.83% to $34.0 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were $34.0 million in Q1 2026, -$48.0 million in Q4 2025, and -$16.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.00 Mn |
| Dec 31, 2025 | -48.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | 14.00 Mn |
| Dec 31, 2024 | -152.00 Mn |
| Sep 30, 2024 | -42.00 Mn |
| Jun 30, 2024 | -101.00 Mn |
| Mar 31, 2024 | -43.00 Mn |
| Dec 31, 2023 | -21.00 Mn |
| Sep 30, 2023 | -14.00 Mn |
| Jun 30, 2023 | -34.00 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | -176.00 Mn |
| Sep 30, 2022 | -34.00 Mn |
| Jun 30, 2022 | -31.00 Mn |
| Mar 31, 2022 | -45.00 Mn |
| Dec 31, 2021 | 41.00 Mn |
| Sep 30, 2021 | -97.00 Mn |
| Jun 30, 2021 | -11.00 Mn |